A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Pfizer
Novartis
Pfizer
Nested Therapeutics, Inc
Ikena Oncology
Eli Lilly and Company
Aminex Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Bristol-Myers Squibb
Genexine, Inc.
Polaris Group
Shenzhen BinDeBio Ltd.
BBB-Therapeutics B.V.
GE Healthcare
INSYS Therapeutics Inc